We are live on ! Find out more
ARTC

ARTHROCARE CORP
ARTC

Delisted

ARTC was delisted on the 29th of May, 2014.

118 hedge funds and large institutions have $917M invested in ARTHROCARE CORP in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

15% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 40

2% more funds holding

Funds holding: 116118 (+2)

4% more capital invested

Capital invested by funds: $878M → $917M (+$38.9M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less call options, than puts

Call options by funds: $292K | Put options by funds: $334K

Holders
118
Holders Change
+2
Holders Change %
+1.72%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
16
Increased
46
Reduced
40
Closed
13
Calls
$292K
Puts
$334K
Net Calls
-$42K
Net Calls Change
-$139K
Name Holding Trade Value Shares
Change
Change in
Stake
Westfield Capital Management
1
Westfield Capital Management
Massachusetts
$104M +$661K +18,941 +0.6%
Capital Research Global Investors
2
Capital Research Global Investors
California
$83.4M +$4.63M +132,675 +6%
HM
3
HealthCor Management
New York
$81.8M +$1.75M +50,000 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$56.6M +$656K +18,791 +1%
EAM
5
Eagle Asset Management
Florida
$55.2M -$82.2K -2,355 -0.2%
Capital World Investors
6
Capital World Investors
California
$39.3M
BFA
7
BlackRock Fund Advisors
California
$31.1M +$3.57M +102,363 +13%
BIT
8
BlackRock Institutional Trust
California
$28.4M +$601K +17,222 +2%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$26.6M +$24.4K +700 +0.1%
BA
10
BlackRock Advisors
Delaware
$23.7M -$2.88M -82,618 -11%
Renaissance Technologies
11
Renaissance Technologies
New York
$21.1M +$2.07M +59,200 +11%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$20.8M -$47.9K -1,371 -0.2%
State Street
13
State Street
Massachusetts
$19.9M -$63.4K -1,815 -0.3%
PC
14
PointState Capital
New York
$17.8M -$3.49M -100,000 -17%
AAP
15
Ardsley Advisory Partners
Connecticut
$15.8M +$6.86M +196,500 +79%
Northern Trust
16
Northern Trust
Illinois
$14.5M -$480K -13,749 -3%
RG
17
Redmile Group
California
$12.2M +$12M +342,759 New
KCM
18
Kennedy Capital Management
Missouri
$12.2M -$909K -26,037 -7%
GI
19
GAMCO Investors
Connecticut
$11.9M -$20.9K -600 -0.2%
ACM
20
American Capital Management
New York
$10.9M +$243K +6,976 +2%
TI
21
Turner Investments
Pennsylvania
$9.33M -$1.08M -30,964 -11%
AIMCA
22
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$9.2M +$9.03M +258,636 New
Norges Bank
23
Norges Bank
Norway
$8.28M +$2.01M +57,471 +33%
WMSA
24
Weiss Multi-Strategy Advisers
New York
$8.04M
GF
25
Gabelli Funds
New York
$8.01M -$112K -3,200 -1%

ARTC Hedge Fund Activity: Q3 2013 in Review

118 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ARTHROCARE CORP (ARTC) for Q3 2013, worth a combined $917M — up 4.4% from $878M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ARTC positions and 13 closed out — a net gain of 3 holders — while 46 added to existing stakes and 40 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $12M. The largest seller was SAC Capital Advisors, cutting an estimated $22M.

  • 118 institutional investors held ARTHROCARE CORP (ARTC) as of Q3 2013, up from 116 in Q2 2013.
  • Funds reported $917M of ARTHROCARE CORP stock for Q3 2013, up 4.4% quarter-over-quarter.
  • 16 funds opened new ARTHROCARE CORP positions in Q3 2013 and 13 closed out, a net change of +3 holders.
  • The largest ARTHROCARE CORP buyer in Q3 2013 was Redmile Group, an estimated $12M added.
  • The largest ARTHROCARE CORP seller in Q3 2013 was SAC Capital Advisors, an estimated $22M sold.

Based on aggregated 13F filings for Q3 2013.